Nuvalent Inc (NUVL)
70.95
-1.69
(-2.33%)
USD |
NASDAQ |
May 17, 16:00
70.95
0.00 (0.00%)
After-Hours: 20:00
Nuvalent Total Liabilities (Quarterly): 33.43M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 33.43M |
| December 31, 2023 | 31.82M |
| September 30, 2023 | 29.10M |
| June 30, 2023 | 20.80M |
| March 31, 2023 | 17.02M |
| December 31, 2022 | 19.48M |
| September 30, 2022 | 12.98M |
| Date | Value |
|---|---|
| June 30, 2022 | 10.04M |
| March 31, 2022 | 8.124M |
| December 31, 2021 | 8.787M |
| September 30, 2021 | 6.842M |
| June 30, 2021 | 191.24M |
| March 31, 2021 | 3.11M |
| December 31, 2020 | 41.97M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.11M
Minimum
Mar 2021
191.24M
Maximum
Jun 2021
31.05M
Average
18.25M
Median
Total Liabilities (Quarterly) Benchmarks
| Geron Corp | 137.21M |
| Verastem Inc | 77.32M |
| Karyopharm Therapeutics Inc | 373.41M |
| Syndax Pharmaceuticals Inc | 51.14M |
| AnaptysBio Inc | 358.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 708.47M |
| Shareholders Equity (Quarterly) | 675.04M |